The National Biosafety Authority (NBA) has approved another HIV vaccine clinical trial for the prevention of HIV-1 infection in women. The phase two trial which involves about 500 participants in Lusaka and Ndola will be conducted by the Centre for Infectious Disease Research in Zambia (CIDRZ) and the Zambia Emory HIV Research Project (ZEHRP).


  • Press Statement – NBA approves HIV Prevention vaccine Clinical trials